{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04643002: Phase 1/Phase 2 Interventional Recruiting Plasma Cell Myeloma Refractory
(2021)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04126200: Phase 1/Phase 2 Interventional Recruiting Multiple Myeloma
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02561962: Phase 1 Interventional Completed Multiple Myeloma
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04364230: Phase 1/Phase 2 Interventional Active, not recruiting Melanoma
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01040832: Phase 2 Interventional Completed Squamous Cell Carcinoma of the Head and Neck Cancer
(2009)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03775538: Phase 1/Phase 2 Interventional Completed Parkinson Disease
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01304784: Phase 1 Interventional Completed HER-2 Gene Amplification
(2011)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01868022: Phase 1 Interventional Completed Neoplasms
(2013)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02443155: Phase 2 Interventional Completed Diabetes
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02298946: Phase 1 Interventional Completed Colorectal Cancer
(2014)
Source URL:
Class:
CONCEPT